Hibiscus Sabdariffa Extract Improves Hepatic Steatosis, Partially Through IRS-1/Akt and Nrf2 Signaling Pathways in Rats Fed a High Fat Diet

Overview

Journal Sci Rep

Specialty Science

Date 2022 Apr 29

PMID 35487948

Authors

Janjira Prasomthong

Nanteetip Limpeanchob

Supawadee Daodee

Pennapa Chonpathompikunlert

Sakara Tunsophon

Affiliations

Soon will be listed here.

Abstract

Non-alcoholic fatty liver disease (NAFLD) has become a major world-wide health problem and is characterized by lipid accumulation in the liver induced by high fat diet (HFD) consumption. It is usually associated with inflammation, oxidative stress, and insulin resistance. Roselle extract (Hibiscus sabdariffa) is an herb which is used in traditional medicine. However, further study is necessary to represent the mechanism of NAFLD and find new preventive strategies. This study aims to investigate the protective effects of roselle extract on NAFLD rat models. Male Sprague-Dawley rats (n = 35) were divided into 5 groups, control, HFD, HFD + Simvastatin (HFD + SIM), HFD + 250 mg/kg BW, and HFD + 500 mg/kg BW of roselle extract (HFD + R250 and HFD + R500, respectively). The results showed that roselle extract reduced hepatic lipid contents, de novo lipogenesis enzymes, microsomal triglyceride transfer protein, inflammatory cytokines, malondialdehyde, and increased antioxidant properties, transporter related with lipoprotein uptake, and insulin signal proteins. Comparing to SIM, the HFD + R500 group exhibited the greater benefit in terms of anti-hepatic steatosis, antioxidant properties, and an ability to improve insulin resistance. This study demonstrates that roselle extract improved antioxidant properties and attenuated hepatic steatosis, liver inflammation, oxidative stress, and insulin resistance in HFD-induced NAFLD in rats, which could be used for NAFLD prevention.

Citing Articles

Association of Hibiscus sabdariffa and high-intensity interval training induces reduction in adiposity and beneficial metabolic adaptations in obesity without changes in lipid metabolism.

Oliveira D, Giordani M, Luvizotto R, Nascimento A, Santos M, Santos K Braz J Med Biol Res. 2024; 57:e13676.

PMID: 39504065 PMC: 11540260. DOI: 10.1590/1414-431X2024e13676.

Study on the mechanism of Shenling Baizhu powder on the pathogenesis of pregnancy complicated with non-alcoholic fatty liver, based on PI3K/AKT/mTOR signal pathway.

Le Y, Wang Z, Zhang Q, Miao L, Wang X, Han G Eur J Histochem. 2024; 68(3).

PMID: 39287141 PMC: 11459917. DOI: 10.4081/ejh.2024.4093.

Mechanism of Action and Related Natural Regulators of Nrf2 in Nonalcoholic Fatty Liver Disease.

Yu W, Zhang F, Meng D, Zhang X, Feng Y, Yin G Curr Drug Deliv. 2024; 21(10):1300-1319.

PMID: 39034715 DOI: 10.2174/0115672018260113231023064614.

The effects of weight loss interventions on children and adolescents with non-alcoholic fatty liver disease: A systematic review and meta-analysis.

Sohouli M, Bagheri S, Fatahi S, Rohani P Obes Sci Pract. 2024; 10(3):e758.

PMID: 38682153 PMC: 11047132. DOI: 10.1002/osp4.758.

Experimental model and novel therapeutic targets for non-alcoholic fatty liver disease development.

Jin Y, Heo K Korean J Physiol Pharmacol. 2023; 27(4):299-310.

PMID: 37386828 PMC: 10316197. DOI: 10.4196/kjpp.2023.27.4.299.

References

Forni C, Facchiano F, Bartoli M, Pieretti S, Facchiano A, DArcangelo D . Beneficial Role of Phytochemicals on Oxidative Stress and Age-Related Diseases. Biomed Res Int. 2019; 2019:8748253. PMC: 6475554. DOI: 10.1155/2019/8748253. View

Sengupta P . The Laboratory Rat: Relating Its Age With Human's. Int J Prev Med. 2013; 4(6):624-30. PMC: 3733029. View

Omagari K, Asakawa E, Sasao M, Narita S, Hisano M, Fukuda A . Age-Related Alterations of Nonalcoholic Steatohepatitis in Sprague-Dawley Rats Fed a High-Fat and High-Cholesterol Diet. J Nutr Sci Vitaminol (Tokyo). 2019; 65(4):349-356. DOI: 10.3177/jnsv.65.349. View

Mnafgui K, Hamden K, Salah H, Kchaou M, Nasri M, Slama S . Inhibitory Activities of Zygophyllum album: A Natural Weight-Lowering Plant on Key Enzymes in High-Fat Diet-Fed Rats. Evid Based Complement Alternat Med. 2012; 2012:620384. PMC: 3520503. DOI: 10.1155/2012/620384. View

Golomb B, Evans M . Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs. 2009; 8(6):373-418. PMC: 2849981. DOI: 10.2165/0129784-200808060-00004. View

Ochani P, DMello P . Antioxidant and antihyperlipidemic activity of Hibiscus sabdariffa Linn. leaves and calyces extracts in rats. Indian J Exp Biol. 2009; 47(4):276-82. View

Garcia-Cortes M, Robles-Diaz M, Stephens C, Ortega-Alonso A, Lucena M, Andrade R . Drug induced liver injury: an update. Arch Toxicol. 2020; 94(10):3381-3407. DOI: 10.1007/s00204-020-02885-1. View

Padilla-Camberos E, Flores-Fernandez J, Fernandez-Flores O, Gutierrez-Mercado Y, Carmona-de la Luz J, Sandoval-Salas F . Hypocholesterolemic Effect and In Vitro Pancreatic Lipase Inhibitory Activity of an Opuntia ficus-indica Extract. Biomed Res Int. 2015; 2015:837452. PMC: 4442264. DOI: 10.1155/2015/837452. View

Yang M, Peng C, Chan K, Yang Y, Huang C, Wang C . The hypolipidemic effect of Hibiscus sabdariffa polyphenols via inhibiting lipogenesis and promoting hepatic lipid clearance. J Agric Food Chem. 2009; 58(2):850-9. DOI: 10.1021/jf903209w. View

10.

Gurrola-Diaz C, Garcia-Lopez P, Sanchez-Enriquez S, Troyo-Sanroman R, Andrade-Gonzalez I, Gomez-Leyva J . Effects of Hibiscus sabdariffa extract powder and preventive treatment (diet) on the lipid profiles of patients with metabolic syndrome (MeSy). Phytomedicine. 2009; 17(7):500-5. DOI: 10.1016/j.phymed.2009.10.014. View

11.

Hira T, Suto R, Kishimoto Y, Kanahori S, Hara H . Resistant maltodextrin or fructooligosaccharides promotes GLP-1 production in male rats fed a high-fat and high-sucrose diet, and partially reduces energy intake and adiposity. Eur J Nutr. 2017; 57(3):965-979. DOI: 10.1007/s00394-017-1381-7. View

12.

Lee H, Lee G, Yoon Y, Chae H . and Protects Against High-Fat Diet-Induced Hepatic Steatosis by Enhancing Anti-Oxidation and AMPK Activation. Am J Chin Med. 2019; 47(6):1253-1270. DOI: 10.1142/S0192415X19500642. View

13.

Bjornsson E . Hepatotoxicity of statins and other lipid-lowering agents. Liver Int. 2016; 37(2):173-178. DOI: 10.1111/liv.13308. View

14.

Hadwan M, Ali S . New spectrophotometric assay for assessments of catalase activity in biological samples. Anal Biochem. 2017; 542:29-33. DOI: 10.1016/j.ab.2017.11.013. View

15.

Herranz-Lopez M, Olivares-Vicente M, Boix-Castejon M, Caturla N, Roche E, Micol V . Differential effects of a combination of Hibiscus sabdariffa and Lippia citriodora polyphenols in overweight/obese subjects: A randomized controlled trial. Sci Rep. 2019; 9(1):2999. PMC: 6395806. DOI: 10.1038/s41598-019-39159-5. View

16.

Bertot L, Adams L . The Natural Course of Non-Alcoholic Fatty Liver Disease. Int J Mol Sci. 2016; 17(5). PMC: 4881593. DOI: 10.3390/ijms17050774. View

17.

Janson B, Prasomthong J, Malakul W, Boonsong T, Tunsophon S . Hibiscus sabdariffa L. calyx extract prevents the adipogenesis of 3T3-L1 adipocytes, and obesity-related insulin resistance in high-fat diet-induced obese rats. Biomed Pharmacother. 2021; 138:111438. DOI: 10.1016/j.biopha.2021.111438. View

18.

Tian B, Zhao J, Xie X, Chen T, Yin Y, Zhai R . Anthocyanins from the fruits of Murray improve high-fat diet-induced insulin resistance by ameliorating inflammation and oxidative stress in mice. Food Funct. 2021; 12(9):3855-3871. DOI: 10.1039/d0fo02936j. View

19.

Singh S, Osna N, Kharbanda K . Treatment options for alcoholic and non-alcoholic fatty liver disease: A review. World J Gastroenterol. 2017; 23(36):6549-6570. PMC: 5643281. DOI: 10.3748/wjg.v23.i36.6549. View

20.

Gonzalez A, Huerta-Salgado C, Orozco-Aguilar J, Aguirre F, Tacchi F, Simon F . Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD). Oxid Med Cell Longev. 2020; 2020:1617805. PMC: 7603619. DOI: 10.1155/2020/1617805. View